Abstract
8 male schizophrenic patients participated in a double-blind, cross over study of the extrapyramidal side-effects of haloperidol and clozapine (acute dystonia, Parkinsonism and tardive dyskinesia), together with their effect on homo-vanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the cerebrospinal fluid (CSF). Haloperidol (9 mg/day) caused Parkinsonism, reduced tardive dyskinesias and increased the HVA concentration in the CSF. Clozapine (225 mg/day) had no effect on the neurological phenomena but reduced HVA and 5-HIAA concentrations in the CSF. During the discontinuation phase following the administration of haloperidol, tardive dyskinesia occurred or was aggravated; this did not occur after administration of clozapine. Accordingly, it is suggested that clozapine does not induce dopaminergic hypersensibility and, therefore, will not induce tardive dyskinesias.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andén, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K., Ungerstedt, U.: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Europ. J. Pharmacol. 11, 303–314 (1970)
Andén, N.-E., Stock, G.: Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system. J. Pharm. Pharmacol. 25, 346–348 (1973)
Angst, J.: Ergebnisse eines Doppelblindversuches von HF 1854 (8-Chlor-11-(4-methyl-1-piperazinyl)-5H-dibenzo (b,e) (1, 4) diazepin im Vergleich zu Levomepromazin. Pharmakopsychiat. 4, 192–200 (1971)
Asper, H., Baggiolini, M., Bürki, H. R., Lauener, H., Ruch, W., Stille, G.: Tolerance phenomena with neuroleptics. Catalepsy apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol. Europ. J. Pharmacol. 22, 287–294 (1973)
Ayd, F. J.: Persistent dyskinesia: a neurological complication of major tranquilizers. Med. Sci. 18, 32–40 (1967)
Ayd, F. J.: Neuroleptics and antiparkinsonian drugs. Int. Drug. Ther. Newsletter 6, 33 (1971)
Ayd, F. J.: Haloperidol: 15 years of clinical experience. Dis. nerv. Syst. 33, 459–469 (1972)
Bartholini, G., Haefely, W., Jalfre, M., Keller, H. H., Pletscher, A.: Effects of clozapine on cerebral catecholaminergic neurone systems. Brit. J. Pharmacol. 46, 736–740 (1972)
Bowers, M. B.: 5-Hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) following probenecid in acute psychotic patients treated with phenothiazines Psychopharmacologia (Berl.) 28, 309–318 (1973)
Bürki, H. R., Ruch, W., Asper, H., Baggiolini, M., Stille, G.: Pharmakologische und neurochemische Wirkungen von Clozapin: neue Gesichtspunkte in der medikamentösen Behandlung der Schizophrenie. Schweiz, med. Wschr. 103, 1716–1724 (1973)
Chase, T. N.: Central monoamine metabolism in man. Arch. Neurol. (Chic.) 29, 349–351 (1973)
Chase, T. N., Schnur, J. A., Gordon, E. K.: Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders. Neuropharmacology 9, 265–268 (1970)
Christensen, E., MØller, J. E., Faurbye, A.: Neuropathological investigations of 28 brains from patients with dyskinesia. Acta psychiat. scand. 46, 14–23 (1970)
Crane, G. E.: Tardive dyskinesia in patients treated with major neuroleptics: A review of the literature. Amer. J. Psychiat. 124, 40–48 (1968)
Crane, G. E.: Persistent dyskinesia. Brit. J. Psychiat. 122, 395–405 (1973)
DiMascio, A., Demirgian, E.: Antiparkinson drug overuse. Psychosomatics 11, 596–601 (1970)
Faurbye, A.: The structural and biochemical basis of movement disorders in treatment with neuroleptic drugs and in extrapyramidal diseases. Compr. Psychiat. 11, 205–225 (1970)
Fischer-Cornelssen, K., Ferner, U., Steiner, H.: Multifokale Psychopharmakaprüfung. Arzneimittel-Forsch. (Drug Res.) 24, 1006–1007 (1974)
Fjalland, B., MØller-Nielsen, I.: Enhancement of methylphenidate-induced stereotypies by repeated administration of neuroleptics. Psychopharmacologia (Berl.) 34, 105–109 (1974)
Fog, R.: Neuroleptic action of clozapine injected into various brain areas in rats. J. Pharmacol. 5, suppl. 2, 32 (1974)
Gerlach, J., Reisby, N., Randrup, A.: Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Psychopharmacologia (Berl.) 34, 21–35 (1974)
Gerlach, J., Koppelhus, P., Helweg, E., Monrad, A.: Clozapine and haloperidol in a single-blind corss-over trial: Therapeutic and biochemical aspects in the treatment of schizophrenia. Acta psychiat. 50, 410–424 (1974)
Hyttel, J.: Effect of neuroleptics on the disappearance rate of 3H-labelled catecholamines formed from 14C-tyramine in mouse brain. J. Pharm. Pharmacol. 26, 588–596 (1974)
Kazamatsuri, H., Chien, C, Cole, J. O.: Treatment of tardive dyskinesia. II. Shortterm efficacy of dopamine-blocking agents haloperidol and thiopropazate. Arch. gen. Psychiat. 27, 100–103 (1972)
Klawans, H. L.: The pharmacology of tardive dyskinesia. Amer. J. Psychiat. 130, 82–86 (1973)
Pakkenberg, H., Fog, R., Nilakantan, B.: The long-term effects of perphenazine enanthate on the rat brain. Psychopharmacologia (Berl.) 29, 329–336 (1973)
Papeschi, R.: Dopamine extrapyramidal system and psychomotor function. Psychiat. Neurol. Neurochir. (Amst.) 75, 13–48 (1972)
Papeschi, R., McClure, D. J.: Homovanillic and 5-hydroxyindoleacetic acid in cerebrospinal fluid of depressed patients. Arch. gen. Psychiatry 25, 354–358 (1971)
Post, R. M., Kotin, J., Hoodwin, F. K., Gordon, E. K.: Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness. Amer. J. Psychiat. 130, 67–72 (1973)
Sayers, A. C, Bürki, H., Ruch, W., Asper, H.: Hypersensitivity of striatal dopamine receptors in the rat. A method of predicting the occurrence of tardive dyskinesias after antipsychotic drugs. J. Pharmacol. 5, suppl. 2, 88 (1974)
Schildkrut, R., Ackenheil, M., Eben, R. Raise, I., Rüther, E.: Effect of haloperidol treatment on metabolism of biogenic amines, extrapyramidal and psychopathological symptoms. J. Pharmacol. 5, suppl. 2, 90 (1974)
Sedvall, G., NybÄck, H.: Effect of clozapine and some other antipsychotic agents on synthesis and turnover of dopamine formed from 14C-tyrosine in mouse brain. Israel J. med. Sci., suppl. to vol. 9, 24–30 (1973)
Siegel, G. J., Mones, R. J.: Modification of choreiform activity by haloperidol. J. Amer. med. Ass. 216, 675–676 (1971)
Sommer, H.: Die aktive psychiatrische Therapie unter Berücksichtigung tierexperimenteller Untersuchungen, pp. 58–78. Jena: VEB G. Fischer 1971
Stawarz, F. J., Robinson, S., Sulser, F., Dingell, J. V.: On the significance of the increase of homovanillic acid (HVA) caused by antipsychotics in corpus striatum and limbic forebrain. Fed. Proc. 33, 246 (1974)
Stille, G., Lauener, H., Eichenberger, E.: The pharmacology of 8-chloro-ll-(4-methyl-1-piperazinyl)-5H-dibenzo [b,e] [1,4] diazepine (clozapine). Farmaco, Ed. prat. 26, 603–625 (1971)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gerlach, J., Thorsen, K. & Fog, R. Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients. Psychopharmacologia 40, 341–350 (1975). https://doi.org/10.1007/BF00421473
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00421473